CALASIA PHARMACEUTICALS, INC.

Basic Information

6330 Nancy Ridge Drive
SAN DIEGO, CA, 92121-3220

http://www.calasiapharma.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 831901231
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 3


  1. Development of Flavivirus Antivirals Targeting Dengue Virus and WNV Protease

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Mosquito-borne members of the Flavivirus family include four serotypes of dengue virus (DENV1-4) and West Nile Virus (WNV) and are classified as re-emerging pathog ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Discovery and Development of Novel Glucose Dependent Partial Glucokinase Activato

    Amount: $201,930.00

    DESCRIPTION (provided by applicant): Type 2 diabetes (T2DM) is a chronic metabolic disease that affects the quality and longevity of life. Currently it is estimated that about 246 million people world ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Selective and dual-acting Hsp90 and TRAP1 inhibitors

    Amount: $279,068.00

    DESCRIPTION (provided by applicant): Although the existing agents for treating cancer have shown promising results, the inherent genetic plasticity of the cancer cells continues to undermine the effic ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government